amitriptyline has been researched along with stilbenes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acharya, C; Andersen, MR; Omiecinski, CJ; Schilter, B | 1 |
LEREBOULLET, J | 1 |
Arbabi, E; Atyabi, F; Dinarvand, R; Hassanzadeh, P | 1 |
3 other study(ies) available for amitriptyline and stilbenes
Article | Year |
---|---|
Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers.
Topics: Allyl Compounds; Amitriptyline; Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Northern; Brain; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DDT; Enzyme Induction; Epoxide Hydrolases; Liver; Male; Mixed Function Oxygenases; Phenobarbital; Phenytoin; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steroid Hydroxylases; Stilbenes; Sulfides | 2000 |
[THE NEW ANTIEPILEPTIC AGENTS].
Topics: Acetazolamide; Adrenocorticotropic Hormone; Amitriptyline; Anticonvulsants; Chlordiazepoxide; Dichlorphenamide; Epilepsy; Hydantoins; Stilbenes; Sulfones | 1963 |
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders.
Topics: Amitriptyline; Animals; Antioxidants; Brain; Camphanes; Cannabinoids; Clonazepam; Dose-Response Relationship, Drug; Endocannabinoids; Male; Nerve Growth Factor; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resveratrol; Signal Transduction; Stilbenes | 2016 |